DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Recruiting now · Not applicable
Conditions studied: Esophageal Cancer
In brief
To prospectively collect medical images and clinical data related to esophageal cancer using 4D Free Breathing DCE-MRI technology, to evaluate the image quality in the diagnosis of esophageal cancer, and to predict the efficacy of preoperative neoadjuvant chemoradiotherapy for esophageal cancer.
Key facts
- Study ID
- NCT06755866
- Run by
- Yunnan Cancer Hospital
- People needed
- 135
- Starts
- 2024-11-26
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2025-01-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Be 18 years of age and older;
- First diagnosis of esophageal squamous cell carcinoma confirmed by histopathological biopsy;
- The clinical stage is cT1b\~cT2N+; or the clinical stage is cT3\~cT4 any N, (thoracic esophageal cancer, esophagogastric junction cancer);
- There are no contraindications to MRI examination
You may not qualify if…
- Have other primary tumors;
- The image quality does not meet the diagnostic criteria;
- Those who do not cooperate with the inspection;
- Patients who have received prior chemoradiotherapy
Where it is running
- Yunnan Cancer Hospital — Kunming, Yunnan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.